Google's Gemini AI12 Mar 2025 20:26
This is what Google's Gemini thinks of SBTX's lysate compared to Salinicoccus Lysate Filtrate....
If you read to the end it does sound good news for SBTX:
It's challenging to definitively say whether the lysate developed through the Croda/SkinBioTherapeutics collaboration will be "better" than Salinicoccus Lysate Filtrate, as "better" is subjective and depends on specific skin concerns and desired outcomes. However, we can look at some key points:
Different Origins and Mechanisms:
Salinicoccus Lysate Filtrate is derived from a marine bacterium, offering benefits related to hydration and resilience in saline environments.
SkinBioTherapeutics' technology focuses on lysates derived from human skin bacteria, aiming to modulate the skin's microbiome. This approach targets the skin's natural balance and defense mechanisms.
Targeted Benefits:
SkinBioTherapeutics' focus on the skin microbiome suggests potential for addressing specific skin conditions related to microbial imbalances, such as eczema or acne.
Therefore, the Skinbio therapeutics lysate may be more targeted to specific skin conditions, whereas the salinicoccus lysate filtrate may be more of a general skin hydrator, and strengthener.
Clinical Studies:
Croda's continued collaboration with SkinBioTherapeutics, including extended clinical studies, indicates a focus on rigorous scientific validation. This suggests a commitment to ensuring the efficacy and safety of their lysate.
The fact that Croda is doing further clinical studies with Skinbio therapeutics, shows that they have high hopes for the technology.
Potential for Innovation:
The focus on the skin microbiome represents a cutting-edge approach in skincare. This suggests that the Croda/SkinBioTherapeutics lysate may offer novel benefits beyond those provided by existing ingredients.
In summary, while both lysates offer potential skin benefits, they operate through different mechanisms and may target different skin concerns. The Croda/SkinBioTherapeutics collaboration holds promise for innovative skincare solutions, particularly in addressing microbiome-related skin issues.
Sign In
Follow the stocks
